Articles By Keyword

. "Quantile regression for censored mixed-effects models with applications to HIV studies.." Stat Interface. 2015;8(2):203-215. Pub Med
. "Statistical methods and computing for big data.." Stat Interface. 2016;9(4):399-414. Pub Med
. "Two-stage design for phase II oncology trials with relaxed futility stopping.." Stat Interface. 2016;9(1):93-98. Pub Med
. "Double sparsity kernel learning with automatic variable selection and data extraction.." Stat Interface. 2018;11(3):401-420. Pub Med
. "Network meta-regression for ordinal outcomes: Applications in comparing Crohn's disease treatments.." Stat Med. 2020;():. Pub Med
. "Semiparametric regression models and sensitivity analysis of longitudinal data with nonrandom dropouts.." Stat Neerl. 2010;64(2):133-156. Pub Med
. "An exponential bound for Cox regression.." Stat Probab Lett. 2012;82(7):1267-1272. Pub Med
. "Q- and A-learning methods for estimating optimal dynamic treatment regimes.." Stat Sci. 2014;29(4):640-661. Pub Med
. "Functional linear regression models for nonignorable missing scalar responses.." Stat Sin. 2018;28(4):1867-1886. Pub Med
. "Adaptive estimation with partially overlapping models.." Stat Sin. 2016;26(1):235-253. Pub Med
. "Marginal structural Cox models with case-cohort sampling.." Stat Sin. 2016;26(2):509-526. Pub Med
. "Bayesian sensitivity analysis of statistical models with missing data.." Stat Sin. 2014;24(2):871-896. Pub Med
. "Empirical likelihood for estimating equations with nonignorably missing data.." Stat Sin. 2014;24(2):723-747. Pub Med
. "On varying-coefficient independence screening for high-dimensional varying-coefficient models.." Stat Sin. 2014;24(4):1735-1752. Pub Med
. "On estimation of the optimal treatment regime with the additive hazards model." Stat Sin. 2018;28(3):1539-1560. Pub Med
. "Bayesian inference of hidden gamma wear process model for survival data with ties.." Stat Sin. 2015;25(4):1613-1635. Pub Med
. "Moment-based method for random effects selection in linear mixed models.." Stat Sin. 2012;22(4):1539-1562. Pub Med
. "Joint structure selection and estimation in the time-varying coefficient Cox model. ." Stat Sin. 2016;26(2):547-567. Pub Med
. "Entropy learning for dynamic treatment regimes.." Stat Sin. 2019;29(4):1633-1655. Pub Med
. "Semiparametric regression analysis of repeated current status data.." Stat Sin. 2017;27(3):1079-1100. Pub Med
. "Semiparametric ROC analysis using accelerated regression models.." Stat Sin. 2013;23():829-851. Pub Med
. "Penalized Q-Learning for dynamic treatment regimens.." Stat Sin. 2015;25(3):901-920. Pub Med
. "Bayesian modeling and inference for nonignorably missing longitudinal binary response data with applications to HIV prevention trials.." Stat Sin. 2018;28():1929-1963. Pub Med
. "Surface estimation, variable selection, and the nonparametric oracle property.." Stat Sin. 2011;21(2):679-705. Pub Med
. "Discussion of the Paper by R. L. Prentice and Y. Huang - Optimal Designs and Efficient Inference for Biomarker Studies.." Stat Theory Relat Fields. 2018;2(1):21-22. Pub Med
. "Deep advantage learning for optimal dynamic treatment regime.." Stat Theory Relat Fields. 2018;2(1):80-88. Pub Med
. "Online updating of statistical inference in the big data setting.." Technometrics. 2016;58(3):393-403. Pub Med
. "Discussion of the paper "Clustering random curves under spatial interdependence with application to service accessibility" by Jiang and Serban.." Technometrics. 2012;54(2):129-133. Pub Med
. "Assessing tuning parameter selection variability in penalized regression.." Technometrics. 2019;61(2):154-164. Pub Med
. "Cook's distance measures for varying coefficient models with functional responses.." Technometrics. 2015;57(2):268-280. Pub Med
. "A junction coverage compatibility score to quantify the reliability of transcript abundance estimates and annotation catalogs.." Life Sci Alliance. 2019;2(1):. Pub Med
. "Semiparametric sieve maximum likelihood estimation under cure model with partly interval censored and left truncated data for application to spontaneous abortion.." Lifetime Data Anal. 2019;25(3):507-528. Pub Med
. "Increase in speech recognition due to linguistic mismatch between target and masker speech: monolingual and simultaneous bilingual performance.." J Speech Lang Hear Res. 2014;57(3):1089-97. Pub Med
. "Semiparametric estimation of the accelerated failure time model with partly interval-censored data.." Biometrics. 2017;73(4):1161-1168. Pub Med
. "Improved doubly robust estimation when data are monotonely coarsened, with application to longitudinal studies with dropout.." Biometrics. 2011;67(2):536-45. Pub Med
. "On optimal treatment regimes selection for mean survival time.." Stat Med. 2015;34(7):1169-84. Pub Med
. "Subgroup detection and sample size calculation with proportional hazards regression for survival data.." Stat Med. 2017;36(29):4646-4659. Pub Med
. "Clinical prognostic model for older patients with advanced non-small cell lung cancer.." J Geriatr Oncol. 2019;10(4):555-559. Pub Med
. "Inference on treatment effects from a randomized clinical trial in the presence of premature treatment discontinuation: the SYNERGY trial.." Biostatistics. 2011;12(2):258-69. Pub Med
. "Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.." Eur Heart J. 2016;37(4):412-22. Pub Med
. "Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.." Eur Heart J Acute Cardiovasc Care. 2013;2(3):246-55. Pub Med
. "Optimal two-stage dynamic treatment regimes from a classification perspective with censored survival data.." Biometrics. 2018;74(4):1180-1192. Pub Med
. "Optimizing delivery of a behavioral pain intervention in cancer patients using a sequential multiple assignment randomized trial SMART.." Contemp Clin Trials. 2017;57():51-57. Pub Med
. "Comparing oncology clinical programs by use of innovative designs and expected net present value optimization: Which adaptive approach leads to the best result?." J Biopharm Stat. 2017;27(3):457-476. Pub Med
. "Genome analysis and pleiotropy assessment using causal networks with loss of function mutation and metabolomics.." BMC Genomics. 2019;20(1):395. Pub Med
. "Sample size considerations of prediction-validation methods in high-dimensional data for survival outcomes.." Genet Epidemiol. 2013;37(3):276-82. Pub Med
. "Sample size considerations of prediction-validation methods in high-dimensional data for survival outcomes.." Genet Epidemiol. 2013;37(3):276-82. Pub Med
. "Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial.." Lancet Oncol. 2017;18(6):732-742. Pub Med
. "Genetic association analysis under complex survey sampling: the Hispanic Community Health Study/Study of Latinos.." Am J Hum Genet. 2014;95(6):675-88. Pub Med
. "Assessing the causal effect of organ transplantation on the distribution of residual lifetime.." Biometrics. 2013;69(4):820-9. Pub Med